27. January 2021
We are delighted to announce that RAMCON has been selected as partner in the Nordic Countries by Swiss-based Cytosurge, inventor and provider of the patented FluidFM single cell manipulation technology. The FluidFM BIO Series lab solutions enable cutting-edge experiments in life sciences and nanotechnology, such as neuronal cell network patterning, multiplexed CRISPR gene editing, and unprecedented fast cell line development. We are excited about the partnership and look forward to a fruitful collaboration.